Background: The development of heart failure after acute myocardial infarction (MI)
identified many kinds of stem cells with the ability to regenerate and repair damaged myocardium after MI. These include embryonic stem cells, mesenchymal stem cells, multipotent adult progenitor cells, etc. [4] [5] [6] More recently, cardiac stem cells (CSCs) were successfully isolated and identified from rats as a population of c-kit + , sca- to form various nonhematopoietic tissues including heart. CSCs administered during acute phase have been proved to temporarily improve myocardial function and remodeling. [7] [8] [9] Our previous studies have demonstrated that after transplanting into rats with myocardial infarction, CSCs expressed α-sarcomeric actin (muscle marker), von
Willebrand factor (endothelium marker), and α-smooth muscle actin (smooth muscle marker) in the infarct zone and the infarct marginal zone, supporting that CSCs could in vivo differentiate into cardiomyocytes, endothelial cells, and vascular smooth muscle cells in the cardiac microenvironment. 9, 10 However, whether CSCs played the protective effects in left ventricular geometry and function throughout acute to subacute MI remains unclear.
Therefore, this study hypothesized CSCs therapy improved the myocardial function and prevented detrimental remodeling after MI.
| MATERIALS AND METHODS

| Animals
Adult male Sprague-Dawley rats weighing 250-350 g were obtained from the animal experiment center of Sun Yat-sen university and were housed in a standard animal facility with 12-h on and off light conditions. All animals were acclimatized for at least a week before surgery and allowed standard food and water ad libitum. All procedures adhered to the guidelines for the care and use of laboratory animals and the ethical review process of our institution and were approved by the institutional animal care committee.
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| Isolation and culture of cardiac stem cells
Three-day-old Sprague-Dawley rats were anesthetized by intraperitoneal injection of pentobarbital (45 mg/kg). Under sterile conditions, hearts were minced into 1-mm 3 pieces. The pieces were digested with 0.2% trypsin and 0.1% collagenase II for 5 minutes for 4 times. After digestion, pieces were incubated with complete explant medium at 37°C
humidified atmosphere with 5% CO 2 . When reaching 90% confluence, cells were trypsinized with 0.25% trypsin-EDTA and passaged at the ratio of 1:2. The third passage CSCs were used in all experiments.
Cultured CSCs were analyzed with positive markers of c-kit, CD29, CD90.1 and negative markers of CD11b/c, CD34, CD45 by fluorescence-activated cell sorting (FACS) (FACScan flow cytometer;
Becton Dickinson, Sparks, MD, USA) as reported previously.
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For further tracing cell distribution in the heart, suspended CSCs were labeled with fluorescent dyes (PKH26) based on the instruction of PKH26 red fluorescent cell linker kit (Sigma Aldrich, St. Louis, MO, USA) as reported previously.
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| Preparation of rat myocardial infarction model
Twenty male Sprague-Dawley rats were anesthetized by intraperitoneal injection of pentobarbital (45 mg/kg). The trachea was orally intubated with a 14-g cannula mounted on a blunt needle with a 145-angled tip as previously described. 14 The animals were mechanically ventilated with room air at a tidal volume of 0.65 mL/100 g of body weight and a frequency of 100 breaths/min. The electrocardiogram lead II was continuously monitored. A thoracotomy was performed via the left fourth intercostal space. After incising the pericardium and elevating the left atrial appendage, the left anterior descending (LAD) coronary artery was ligated. Successful occlusion was confirmed electrocardiographically by the elevation of the ST segment.
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| Experimental procedures
Two weeks after surgical intervention, the animals were anesthetized, intubated, mechanically ventilated, and received thoracotomy as described above. The animals were randomized to receive injection of either 5 × 10 6 /0.1 mL of CSCs labeled with PKH26 in PBS or PBS alone as a placebo into the infarcted anterior ventricular free wall.
Successful injection was typified by the formation of a bleb covering the infarct zone. The animals were allowed to recover from anesthesia and returned to their cages for the next 4 weeks.
Four weeks after treatment, the animals were anesthetized and tracheal intubated as previously described. A 23-gauge PE-50 catheter was advanced through the left carotid artery and aorta into the left ventricle under constant pressure monitoring. Another PE-50 catheter was advanced from the left femoral artery into the descending aorta for measurement of aortic pressure. ECG lead II was continuously recorded. After the hemodynamic measurement, animals were euthanized with 150 mg/kg of pentobarbital and heart was harvested for molecular biological measurement.
| Measurements
| Echocardiography
Left ventricular geometry and function were echocardiographically measured with Esaote ultrasound system, using a 12. 
| Hemodynamic
Four weeks after injection of CSCs or PBS, mean aorta pressure, LV systolic and end-diastolic pressure (LVSP and LVEDP), and heart rate were recorded on a PC-based data-acquisition system supported by biological function experiment system software (BL-420S; Taimeng, Chengdu, CN). The pressure-related parameters of myocardial contractility, including the maximal rate of LV pressure development and decline (peak +dP/dt and −dP/dt, respectively), Vpm [peak (dP/ dt) Sec−1 /P], and V max [(dP/dt)/P 0 ], were also determined.
| Calculation
Relative Table 1 .
Enzyme-linked immuno sorbent assay (ELISA) was performed to measure VEGF-α or TGF-β1 protein in left ventricular tissue lysate according to the RayBio ® Rat ELISA Kit protocol (RayBiotech Inc., USA).
| Statistical analysis
All quantitative data were described as mean ± SD. Basic comparative statistics were performed using the Student's two-tail t test. All the statistical analyses were performed by SPSS version 15.0 (SPSS, Chicago, IL). A value of P < .05 was considered significant.
| RESULTS
| LAD ligation resulted in disproportion between LV cavity and LV wall and abnormalities of LV function
Typical echocardiological pictures were shown in Figure 1A .
Compared with baseline, rats after LAD ligation exhibited progressive time-dependent LV remodeling 2 weeks after LAD ligation. There were significant structural changes observed, including decrease in the in- wall thickness (37 ± 7% vs 42 ± 2%, P = .01) ( Figure 2B ).
Moreover, the architectural remodeling of the left ventricle led to functional abnormalities. EF and FS were significantly decreased (55 ± 3 vs 84 ± 5; 25 ± 6 vs 49 ± 6, P < .01 for each) ( Figure 2C ).These evidence supported successful establishment of MI model.
| Implantation of CSCs into LV effectively prevented remodeling of LV and improved the function of LV
Compared to the control group, there were significant improvement in and relative wall thickness (46 ± 6 vs 43 ± 7, P = .16) (Figure 2A,B) .With the improvement in LV remodeling, better EF and FS were achieved (80 ± 11 vs 72 ± 8, P = .02; 47 ± 8 vs 35 ± 8, P < .01) ( Figure 2C )
Rats treated with CSCs for 4 weeks displayed an improved systolic function, as proved by higher LV systolic pressure (132 ± 9 vs 119 ± 10, P < .01), mean arterial pressure (102 ± 12 vs 96 ± 10, P = .12), and peak + dP/dt (5033 ± 381 vs 3863 ± 387, P < .01). At the same time, a better diastolic function was achieved, as evidenced by higher peakdP/dt (4293 ± 287 vs 3582 ± 285, P < .01) and a marked decline of LV end-diastolic pressure (3 ± 3 vs 6 ± 4, P = .03). Meaningfully, V pm and V max were significantly improved in CSCs group (220 ± 17 vs 172 ± 40; 87 ± 14 vs 72 ± 9, P < .01 for each). As to the parameter reflecting LV compliance, ESS, EDS, and K were also observed to reduced (37 ± 17 vs 62 ± 33, P = .02; 4 ± 4 vs 8 ± 5, P = .01; 12 ± 8 vs 19 ± 10, P = .03) ( Table 2) .
Gene Forward primer (5′-3′)
Reverse primer (5′-3′)
VEGF-α, vascular endothelial growth factor-α; TGF-β1, transforming growth factor-β1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
T A B L E 1 Oligonucleotide sequences of primers used for RT-PCR
| Identification of CSCs in left ventricle and the expression of VEGF-α in LV tissue
After observing the frozen section of hearts, PKH26-staining CSCs obviously accumulated in the left ventricle especially around the vessels and scars ( Figure 3 ).
The expression of VEGF-α mRNA was observed to be significantly improved in CSCs group when compared to control group, which was consistent with the expression of VEGF-α protein. However, there was no significant alteration in the expression of TGF-β no matter in mRNA or protein level (Figure 4 ).
Compared to the control group, postmortem ventricular wall
weights showed a significant decrease in right ventricular (RV)
weight (411 ± 11vs 452 ± 10, P < .01), the ratio of RV-to-body weight (1.09 ± 0.02 vs 1.21 ± 0.01, P < .01), and LV-to-body weight (2.13 ± 0.02 vs 2.16 ± 0.02, P = .01), suggesting improvement in pulmonary and left ventricle hypertension in the CSCs group (Table 3) .
| DISCUSSION
Based on our previous finding that CSCs transplanting into rats with Our study longitudinally documented the in vivo changes in LV geometry after trans-mural anterior MI. An early cavity dilatation, indicated by thinness of infarcted wall and compensated thickness of noninfarcted wall, was observed occurring within 2 weeks and deteriorate in the next 4 weeks in the control group. This was consistent to previous studies suggesting the rapid evolution of necrosis followed by automatic healing of a large territory in the anterolateral wall without reperfusion or salvage of infarct border zones. 22 These progressive architectural changes in this rat model of MI provided suggestion for extension of appropriate time for therapeutic intervention. It has been proved that implantation of CSCs into left ventricle in an early phage of MI prevented thinness of infarcted wall and dilation of LV dimension. However, our study showed another interesting finding that relatively lower hypertrophy of noninfarcted walls was observed after implantation of CSCs, which was contrast to the previous studies that noninfarcted myocardium was compensated hypertrophy. 22 It raised the negative presume that whether decompensation occurred in CSCs group. We further found higher relative wall thickness in CSCs group, implying adequate hypertrophy of the nonmyocardium, and significant higher LV compliance as evidenced by lower ESS, EDS, and elastic stiffness constant.
Depressed EF and FS were observed early after MI, supporting the potential loss of contractile tissue in the infarcted zone and impaired shortening of myocardium in noninfarcted zone by ongoing afterload mismatch postinfarction. Implantation of CSCs has been shown Vpm 72 ± 9 87 ± 14 <.00
V max 172 ± 40 220 ± 17 <.00
CSCs, cardiac stem cells; PBS, phosphate buffer solution; HR, heart rate; MAP, mean artery pressure; LVSP, left ventricle systolic pressure; LVEDP, left ventricle end-diastolic pressure; Peak +dP/dt, maximal rate of LV pressure development; Peak −dP/dt, maximal rate of LV pressure decline; ESS, end-systolic wall stress; EDS, end-diastolic wall stress; K, elastic stiffness constant; Vpm, peak (dP/dt) Sec−1 /P; V max , (dP/dt)/P 0 .
to increase EF, FS, higher LV end-systolic pressure, and peak rate of LV pressure rise in the anesthetized state when compared to control group, suggesting that myocardial contractility was enhanced in the presence of lower end-systolic wall stress. However, no data on the cardiac output, preload, afterload, and volume were provided, which influenced the estimative effectiveness of the above parameter. To overcome the disadvantages, V pm and V max were used to evaluate the contractility, which was independent of preload, afterload, and cardiac output. We found V pm and V max consistently increased in CSCs group.
In addition to impaired myocardial contractility, abnormalities in LV diastolic filling were reported more predominated after MI. Our study demonstrated that CSCs group developed higher LV end-diastolic VEGF-α, vascular endothelial growth factor-α; TGF-β1, transforming growth factor-β1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; *P < .05, **P < .01 between the two groups pressure and peak rate of LV pressure fall, supporting the improvement in diastolic physiology after MI. Notably, this finding was accompanied by a relatively lower end-diastolic wall stress and elastic stiffness constant. Overall, CSCs provided beneficial effects in the chamber compliance after MI.
Cardiomyocyte regeneration and vasculogenesis were demonstrated as two major factors involving in mechanisms of stem cell therapy. Moreover, proremodeling cytokines (such as TGF-β1) and angiogenic factors (such as VEGF-α) have been proved as key regulators of collagen synthesis and angiogenesis following injury or ischemia. 
| CONCLUSION
This study demonstrated implantation of CSCs into left ventricular infarcted tissue significantly prevented the structural remodeling of left ventricle, including dilation of LV cavity, exaggerated thinning of infarcted wall, and hypertrophy of noninfarcted wall, therefore, contributing to an improved systolic and diastolic function in the presence of better cavity compliance. This structural and functional improvement was proved to be partially associated with increased expression of VEGF-α. This would provide more potential for treating coronary disease with CSCs.
